Remedium Bio Inc.

https://www.remedium-bio.com

LinkedIn: https://www.linkedin.com/company/remedium-bio

Remedium Bio, Inc., is a Boston area biotechnology company focused on the development of curative therapies for a broad range of pathologies. The company is founded on the vision of changing lives via curative breakthroughs, grounded in combining proven scientific fundamentals in novel ways, to treat well-characterized pathologies. Remedium’s current lead candidate is a disease-modifying treatment for Osteoarthritis that is based on the clinically validated mechanism of FGF18. Remedium’s scientists discover and develop therapies by appropriately matching treatment modalities with specific disease pathophysiology to replace or augment missing, degenerated, or damaged tissues. Remedium’s pipeline includes gene therapy treatments in the fields of Rheumatology, Endocrinology, Neurology, and Immunology. *

	Start	2021-12-27 existent
	Industry	RMD 1101 AAV gene therapy (Remedium Bio)
	Person	Luppino, Frank (Remedium Bio 202303 CEO)

	Street	1116 Great Plain Avenue Suite 203
	City	02492 Needham, MA
	Tel	+1-978-467-5217
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Biovian Oy. (3/16/23). "Press Release: Remedium Bio and Biovian Have Agreed to Collaborate on Remedium’s First-in-Class Disease Modifying AAV Gene Therapy for Osteoarthritis".

		Record changed: 2023-07-10

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Remedium Bio Inc.

[1] Biovian Oy. (3/16/23). "Press Release: Remedium Bio and Biovian Have Agreed to Collaborate on Remedium’s First-in-Class Disease Modifying AAV Gene Therapy for Osteoarthritis"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)